Research
Testing a Caregiver Intervention: Initial Findings from the PERSEVERE Study
June 3, 2025 Lewy Body dementia (LBD) includes Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB). As the disease progresses, people with LBD need assistance that is not […]
Read More
New RewinD-LB Trial Results Show Promise
March 19, 2025 Earlier this month, CervoMed Pharmaceuticals reported data from an open-label extension phase of the RewinD-LB trial suggesting that the study drug, neflamapimod, may slow cognitive decline in […]
Read More
New imaging study reveals that energy use in the brain begins to decline early in DLB
January 5, 2025 A new research paper from Mayo Clinic and the Karolinska Institutet suggests that the brain’s energy use levels decline measurably early in the course of the disease. […]
Read More
SHIMMER Trial Reports Positive Results
December 18, 2024 This week Cognition Therapeutics reported encouraging topline results from their Phase 2 clinical trial of CT1812, an investigational drug being studied in people with dementia with Lewy […]
Read More
Trial Results – Experimental Drug Shows Promising Results in Phase 2 Trial
November 14, 2024 Clinical trial results reported at a recent scientific conference suggest that the drug nilotinib may improve outcomes in people with dementia with Lewy bodies (DLB). Nilotinib is […]
Read More
LBD Clinical Trials around the World
November 5, 2024 2024 has been an exciting year for clinical trials for people with Lewy body dementia (LBD). Over the past year, you have heard a lot from the […]
Read More
Does kidney injury increase risk for LBD?
September 26, 2024 A new study published in the medical research journal Neurology suggests that sudden worsening of kidney function (referred to as “acute kidney injury”) may nearly double the […]
Read More
Special Research Topic: Right of Withdrawal – What Research Participants Need to Know
September 04, 2024 Clinical trials are the key to unlocking future treatments and preventive strategies for Lewy body dementia (LBD). Only by testing new medications in controlled experiments, called trials, […]
Read More
Eye on Prevention: Clues from Prostate Therapy
August 05, 2024 According to new research from the University of Iowa, medications used for prostate enlargement may provide clues to future strategies to prevent dementia with Lewy bodies (DLB). […]
Read More
New Research Suggests Skin Test Can Detect Dementia with Lewy Bodies
May 29, 2024 Many people who have dementia with Lewy bodies (DLB) experience delay and difficulty with receiving an accurate diagnosis, often seeing multiple specialists before being correctly diagnosed. In […]
Read More